Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 15, 2020
Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine optionDaniel F Hermens, Gabrielle Simcock, Megan Dutton, et al.
The Australian and New Zealand Journal of Psychiatry|December 17, 2025
Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscapeMegan Dutton, Paul Schwenn, Jules Mitchell, et al.
Journal of Affective Disorders|December 2, 2025
Temporal immune effects of Oral ketamine on PTSD: Transcriptomic evidence of short-term inflammation suppression and sustained immune RemodellingNathan J Wellington, Bonnie L Quigley, Ana P Bouças, et al.
Journal of Psychiatric Research|December 2, 2023
Hippocampal subfield volumes predict treatment response to oral ketamine in people with suicidalityMegan Dutton, Amanda Boyes, Adem T Can, et al.
Psychiatry Research. Neuroimaging|August 30, 2021
Six-week oral ketamine treatment for chronic suicidality is associated with increased grey matter volumeCyrana C Gallay, Grace Forsyth, Adem T Can, et al.
Journal of Affective Disorders|March 24, 2023
Treatment response with ketamine in chronic suicidality: An open label functional connectivity studyAdem T Can, Daniel F Hermens, Abdalla Z Mohamed, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 21, 2024
Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidalityZack Y Shan, Adem T Can, Abdalla Z Mohamed, et al.
Pageof 3